Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Hereditary cerebral small vessel disease and stroke

Research output: Contribution to journalJournal articleResearchpeer-review

  1. CT and MRI-based door-to-needle-times for acute stroke patients a quasi-randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. CT and MRI-based door-needle-times for acute stroke patients: A quasi-randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Somatosensory input and oromandibular dystonia

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Workforce Attachment after Ischemic Stroke – The Importance of Time to Thrombolytic Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Age At Menopause: A Female Risk Factor of Stroke?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cerebral small vessel disease is considered hereditary in about 5% of patients and is characterized by lacunar infarcts and white matter hyperintensities on MRI. Several monogenic hereditary diseases causing cerebral small vessel disease and stroke have been identified. The purpose of this systematic review is to provide a guide for determining when to consider molecular genetic testing in patients presenting with small vessel disease and stroke. CADASIL, CARASIL, collagen type IV mutations (including PADMAL), retinal vasculopathy with cerebral leukodystrophy, Fabry disease, hereditary cerebral hemorrhage with amyloidosis, and forkhead box C1 mutations are described in terms of genetics, pathology, clinical manifestation, imaging, and diagnosis. These monogenic disorders are often characterized by early-age stroke, but also by migraine, mood disturbances, vascular dementia and often gait disturbances. Some also present with extra-cerebral manifestations such as microangiopathy of the eyes and kidneys. Many present with clinically recognizable syndromes. Investigations include a thorough family medical history, medical history, neurological examination, neuroimaging, often supplemented by specific examinations e.g of the of vision, retinal changes, as well as kidney and heart function. However molecular genetic analysis is the final gold standard of diagnosis. There are increasing numbers of reports on new monogenic syndromes causing cerebral small vessel disease. Genetic counseling is important. Enzyme replacement therapy is possible in Fabry disease, but treatment options remain overall very limited.

Original languageEnglish
JournalClinical Neurology and Neurosurgery
Volume155
Pages (from-to)45-57
Number of pages13
ISSN0303-8467
DOIs
Publication statusPublished - 22 Feb 2017

    Research areas

  • Journal Article, Review

ID: 50120470